-
1
-
-
0033544305
-
Historical aspects of botulinum toxin. Justinus Kerner (1786-1862) and the "sausage" poison
-
Erbguth FJ, Naumann M. Historical aspects of botulinum toxin. Justinus Kerner (1786-1862) and the "sausage" poison. Neurology 1999;53:1850-3.
-
(1999)
Neurology
, vol.53
, pp. 1850-1853
-
-
Erbguth, F.J.1
Naumann, M.2
-
2
-
-
0032817460
-
On the discovery of Clostridium botulinum
-
Devriese PP. On the discovery of Clostridium botulinum. J History Neurosci 1999;8:43-50.
-
(1999)
J History Neurosci
, vol.8
, pp. 43-50
-
-
Devriese, P.P.1
-
3
-
-
0035961566
-
Botulinum toxin as a biological weapon. Medical and public health management
-
Arnon SS, Schecter R, Inqlesby TV, et al. Botulinum toxin as a biological weapon. Medical and public health management. JAMA 2001;285:1059-70.
-
(2001)
JAMA
, vol.285
, pp. 1059-1070
-
-
Arnon, S.S.1
Schecter, R.2
Inqlesby, T.V.3
-
4
-
-
0019761968
-
Botulinum toxin injection of eye muscles to correct strabismus
-
Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc 1981;79:734-9.
-
(1981)
Trans Am Ophthalmol Soc
, vol.79
, pp. 734-739
-
-
Scott, A.B.1
-
5
-
-
0035411166
-
Focal dystonia: The role of botulinum toxin
-
Tintner R, Jankovic J. Focal dystonia: the role of botulinum toxin. Curr Neurol Neurosci 2001;1:337-45.
-
(2001)
Curr Neurol Neurosci
, vol.1
, pp. 337-345
-
-
Tintner, R.1
Jankovic, J.2
-
7
-
-
2942520007
-
Molecular targets of botulinum toxin at the mammalian neuromuscular junction
-
Whelchel DD, Brehmer TM, Brooks PM, et al. Molecular targets of botulinum toxin at the mammalian neuromuscular junction. Mov Disord 2004;19(Suppl 8):S7-S16.
-
(2004)
Mov Disord
, vol.19
, Issue.8 SUPPL.
-
-
Whelchel, D.D.1
Brehmer, T.M.2
Brooks, P.M.3
-
8
-
-
3042852947
-
Different types of botulinum toxin in humans
-
Eleopra R, Tugnoli V, Quatrale R, et al. Different types of botulinum toxin in humans. Mov Disord 2004;19(Suppl 8):S53-9.
-
(2004)
Mov Disord
, vol.19
, Issue.8 SUPPL.
-
-
Eleopra, R.1
Tugnoli, V.2
Quatrale, R.3
-
9
-
-
3042774054
-
Basic immunological aspects of botulinum toxin therapy
-
Atassi MZ. Basic immunological aspects of botulinum toxin therapy. Mov Dosord 2004;19(Suppl 8):S68-84.
-
(2004)
Mov Dosord
, vol.19
, Issue.8 SUPPL.
-
-
Atassi, M.Z.1
-
10
-
-
0011103440
-
Structural view of botulinum neurotoxin in numerous functional states
-
Brin MF, Hallett M, Jankovic J, eds. Philadelphia: Lippincott Williams & Wilkins
-
Hanson MA, Stevens RC. Structural view of botulinum neurotoxin in numerous functional states. In: Brin MF, Hallett M, Jankovic J, eds. Scientific and therapeutic aspects of botulinum taxin. Philadelphia: Lippincott Williams & Wilkins, 2002:11-28.
-
(2002)
Scientific and Therapeutic Aspects of Botulinum Taxin
, pp. 11-28
-
-
Hanson, M.A.1
Stevens, R.C.2
-
11
-
-
0035030442
-
Molecular mechanisms of neurotransmitter release
-
Fon EA, Edwards RH. Molecular mechanisms of neurotransmitter release. Muscle Nerve 2001;24:581-601.
-
(2001)
Muscle Nerve
, vol.24
, pp. 581-601
-
-
Fon, E.A.1
Edwards, R.H.2
-
12
-
-
0034598654
-
Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle
-
Adler M, Keller JE, Sheridan RE, et al. Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle. Toxicon 2001;39:233-43.
-
(2001)
Toxicon
, vol.39
, pp. 233-243
-
-
Adler, M.1
Keller, J.E.2
Sheridan, R.E.3
-
14
-
-
0033055065
-
Functional repair of motor endplates after botulinum neurotoxin A poisoning: Bi-phasic switch of synaptic activity between nerve sprouts and their parent terminals
-
de Paiva A, Meunier FA, Molgó J, et al. Functional repair of motor endplates after botulinum neurotoxin A poisoning: Bi-phasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci USA 1999;96:3200-5.
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, pp. 3200-3205
-
-
De Paiva, A.1
Meunier, F.A.2
Molgó, J.3
-
15
-
-
0037428398
-
Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons
-
Foran PG, Mohammed N, Lisk GO, et al. Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons. J Biol Chem 2003;278:1363-71.
-
(2003)
J Biol Chem
, vol.278
, pp. 1363-1371
-
-
Foran, P.G.1
Mohammed, N.2
Lisk, G.O.3
-
16
-
-
0032892281
-
Comparison of mouse bioassay and immunaprecipitatian assay for botulinum toxin antibodies
-
Hanna PA, Jankovic J, Vincent A. Comparison of mouse bioassay and immunaprecipitatian assay for botulinum toxin antibodies. J Neurol Neurosurg Psychiatry 1999;66:612-16.
-
(1999)
J Neurol Neurosurg Psychiatry
, vol.66
, pp. 612-616
-
-
Hanna, P.A.1
Jankovic, J.2
Vincent, A.3
-
17
-
-
0036869216
-
Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period
-
Hsiung G-YR, Das SK, Ranawaya R, et al. Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period. Mov Disord 2002;17:1288-93.
-
(2002)
Mov Disord
, vol.17
, pp. 1288-1293
-
-
Hsiung, G.-Y.R.1
Das, S.K.2
Ranawaya, R.3
-
18
-
-
1842856251
-
Cross reaction of tetanus and botulinum neurotoxins A and B and the boosting effect of botulinum neurotoxins A and B on a primary anti-tetanus antibody response
-
Dolimbek BZ, Jankovic J, Atassi MZ. Cross reaction of tetanus and botulinum neurotoxins A and B and the boosting effect of botulinum neurotoxins A and B on a primary anti-tetanus antibody response. Immunol Invest 2002;31:247-62.
-
(2002)
Immunol Invest
, vol.31
, pp. 247-262
-
-
Dolimbek, B.Z.1
Jankovic, J.2
Atassi, M.Z.3
-
19
-
-
0037426445
-
Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia
-
Jankovic J, Vuong KD, Ahsan J. Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia. Neurology 2003;60:1186-8.
-
(2003)
Neurology
, vol.60
, pp. 1186-1188
-
-
Jankovic, J.1
Vuong, K.D.2
Ahsan, J.3
-
20
-
-
0032951652
-
Long-term treatment of cervical dystonia with botulinum toxin A: Efficacy, safety, and antibody frequency
-
German Dystonia Study Group
-
Kessler KR, Skutta M, Benecke R. Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group. J Neurol 1999;246:265-74.
-
(1999)
J Neurol
, vol.246
, pp. 265-274
-
-
Kessler, K.R.1
Skutta, M.2
Benecke, R.3
-
21
-
-
0034783113
-
Needle EMG guidance is rarely required
-
Jankovic J. Needle EMG guidance is rarely required. Muscle Nerve 2001;24:1568-70.
-
(2001)
Muscle Nerve
, vol.24
, pp. 1568-1570
-
-
Jankovic, J.1
-
22
-
-
3042855218
-
Basic and therapeutic aspects of neurotonins
-
Bigalke H, Dressier D, Jankovic J. Basic and therapeutic aspects of neurotonins. Mov Disord 2004; 19(Suppl 8):S1.
-
(2004)
Mov Disord
, vol.19
, Issue.8 SUPPL.
-
-
Bigalke, H.1
Dressier, D.2
Jankovic, J.3
-
23
-
-
0142103736
-
Dystonia: Medical therapy and botulinum toxin
-
Jankovic J. Dystonia: medical therapy and botulinum toxin. Adv Neurol 2004;94:275-86.
-
(2004)
Adv Neurol
, vol.94
, pp. 275-286
-
-
Jankovic, J.1
-
24
-
-
0023142826
-
Botulinum A toxin for cranial-cervical dystonia: A double-blind, placebo-controlled study
-
Jankovic J, Orman J. Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study. Neurology 1987;37:616-23.
-
(1987)
Neurology
, vol.37
, pp. 616-623
-
-
Jankovic, J.1
Orman, J.2
-
25
-
-
0025082911
-
Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm
-
Jankovic J, Schwartz K, Donovan DT. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry 1990;53:633-9.
-
(1990)
J Neurol Neurosurg Psychiatry
, vol.53
, pp. 633-639
-
-
Jankovic, J.1
Schwartz, K.2
Donovan, D.T.3
-
26
-
-
0034132347
-
Treating severe bruxism with botulinum toxin
-
Tan E-K, Jankovic J. Treating severe bruxism with botulinum toxin. J Am Dent Assoc 2000;131:211-16.
-
(2000)
J Am Dent Assoc
, vol.131
, pp. 211-216
-
-
Tan, E.-K.1
Jankovic, J.2
-
27
-
-
0031761314
-
Hemifacial spasm: Clinical correlates and treatments
-
Wang A, Jankovic J. Hemifacial spasm: clinical correlates and treatments. Muscle Nerve 1998;21:1740-7.
-
(1998)
Muscle Nerve
, vol.21
, pp. 1740-1747
-
-
Wang, A.1
Jankovic, J.2
-
28
-
-
0036191227
-
Botulinum toxin a treatment for primary hemifacial spasm: A 10-year multicenter study
-
Defazio G, Abbruzzese G, Girlanda P, et al. Botulinum toxin a treatment for primary hemifacial spasm: a 10-year multicenter study. Arch Neurol 2002;59:418-20.
-
(2002)
Arch Neurol
, vol.59
, pp. 418-420
-
-
Defazio, G.1
Abbruzzese, G.2
Girlanda, P.3
-
29
-
-
3042818315
-
Treatment of cervical dystonia with botulinum toxin
-
Jankovic J. Treatment of cervical dystonia with botulinum toxin. Mov Disord 2004;19(Suppl 8):S109-15.
-
(2004)
Mov Disord
, vol.19
, Issue.8 SUPPL.
-
-
Jankovic, J.1
-
30
-
-
0030670813
-
Symptomatic and functional outcome of surgical treatment of cervical dystonia
-
Krauss JK, Toops EG, Jankovic J, et al. Symptomatic and functional outcome of surgical treatment of cervical dystonia. J Neurol Neurosurg Psychiatry 1997;63:642-8.
-
(1997)
J Neurol Neurosurg Psychiatry
, vol.63
, pp. 642-648
-
-
Krauss, J.K.1
Toops, E.G.2
Jankovic, J.3
-
31
-
-
0032718516
-
Safety and efficacy of Neurobloc (botulinum toxin type B) in type A-responsive cervical dystonia
-
Brashear A, Lew MF, Dykstra DD, et al. Safety and efficacy of Neurobloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology 1999;53:1439-46.
-
(1999)
Neurology
, vol.53
, pp. 1439-1446
-
-
Brashear, A.1
Lew, M.F.2
Dykstra, D.D.3
-
32
-
-
0032716402
-
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia
-
Brin MF, Lew MF, Adler CH, et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology 1999;53:1431-8.
-
(1999)
Neurology
, vol.53
, pp. 1431-1438
-
-
Brin, M.F.1
Lew, M.F.2
Adler, C.H.3
-
33
-
-
0031775483
-
Botulinum toxin type F for treatment of dystonia: Long-term experience
-
Chen R, Karp BI, Hallett M. Botulinum toxin type F for treatment of dystonia: long-term experience. Neurology 1998;51:1494-6.
-
(1998)
Neurology
, vol.51
, pp. 1494-1496
-
-
Chen, R.1
Karp, B.I.2
Hallett, M.3
-
34
-
-
2442579318
-
Botulinum toxin type A injections for the management of the hyperfunctional larynx
-
Brin MF, Hallett M, Jankovic J, eds. Philadelphia: Lippincott Williams & Wilkins
-
Blitzer A, Zalvan C, Gonzalez-Yanez O, et al. Botulinum toxin type A injections for the management of the hyperfunctional larynx. In: Brin MF, Hallett M, Jankovic J, eds. Scientific and therapeutic aspects of botulinum toxin. Philadelphia: Lippincott Williams & Wilkins, 2002:207-16.
-
(2002)
Scientific and Therapeutic Aspects of Botulinum Toxin
, pp. 207-216
-
-
Blitzer, A.1
Zalvan, C.2
Gonzalez-Yanez, O.3
-
35
-
-
0033757911
-
Outcomes assessment following treatment of spasmodic dysphonia with botulinum toxin
-
Courey MS, Garrett CG, Billante CR, et al. Outcomes assessment following treatment of spasmodic dysphonia with botulinum toxin. Ann Otol Rhinol Laryngol 2000;109:819-22.
-
(2000)
Ann Otol Rhinol Laryngol
, vol.109
, pp. 819-822
-
-
Courey, M.S.1
Garrett, C.G.2
Billante, C.R.3
-
36
-
-
0028109629
-
Laryngeal botulinum taxin injections for disabling stuttering in adults
-
Brin MF, Stewart C, Blitzer A, et al. Laryngeal botulinum taxin injections for disabling stuttering in adults. Neurology 1994;44:2262-6.
-
(1994)
Neurology
, vol.44
, pp. 2262-2266
-
-
Brin, M.F.1
Stewart, C.2
Blitzer, A.3
-
37
-
-
0033890804
-
Botulinum toxin for essential tremor of the voice with multiple anatomical sites of tremor: A crossover design study of unilateral versus bilateral injection
-
Warrick P, Dromey C, Irish JC, et al. Botulinum toxin for essential tremor of the voice with multiple anatomical sites of tremor: a crossover design study of unilateral versus bilateral injection. Laryngoscope 2000;110:1366-74.
-
(2000)
Laryngoscope
, vol.110
, pp. 1366-1374
-
-
Warrick, P.1
Dromey, C.2
Irish, J.C.3
-
38
-
-
0026059861
-
Writer's cramp: Treatment with botulinum toxin injections
-
Rivest J, Lees AJ, Marsden CD. Writer's cramp: Treatment with botulinum toxin injections. Mov Disord 1990;6:55-9.
-
(1990)
Mov Disord
, vol.6
, pp. 55-59
-
-
Rivest, J.1
Lees, A.J.2
Marsden, C.D.3
-
39
-
-
0037066095
-
Accuracy of muscle localization without EMG: Implications of limb dystonia
-
Molloy FM, Shill HA, Kaelin-Lang A, et al. Accuracy of muscle localization without EMG: implications of limb dystonia. Neurology 2002;58:805-7.
-
(2002)
Neurology
, vol.58
, pp. 805-807
-
-
Molloy, F.M.1
Shill, H.A.2
Kaelin-Lang, A.3
-
40
-
-
0031919375
-
The corticomotor representation of upper limb muscles in writer's cramp and changes following botulinum toxin injections
-
Byrnes ML, Thickbroom GW, Wilson SA, et al. The corticomotor representation of upper limb muscles in writer's cramp and changes following botulinum toxin injections. Brain 1998;121:977-88.
-
(1998)
Brain
, vol.121
, pp. 977-988
-
-
Byrnes, M.L.1
Thickbroom, G.W.2
Wilson, S.A.3
-
41
-
-
0035470378
-
Treatment of dystonic clenched fist with botulinum toxin
-
Cordivari C, Misra P, Catania S, et al. Treatment of dystonic clenched fist with botulinum toxin. Mov Disord 2001;16:907-13.
-
(2001)
Mov Disord
, vol.16
, pp. 907-913
-
-
Cordivari, C.1
Misra, P.2
Catania, S.3
-
42
-
-
0029873564
-
A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor
-
Jankovic J, Schwartz K, Clemence W, et al. A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor. Mov Disord 1996;11:250-6.
-
(1996)
Mov Disord
, vol.11
, pp. 250-256
-
-
Jankovic, J.1
Schwartz, K.2
Clemence, W.3
-
43
-
-
0035849562
-
A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor
-
Brin MF, Lyons KE, Doucette J, et al. A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor. Neurology 2001;56:1523-8.
-
(2001)
Neurology
, vol.56
, pp. 1523-1528
-
-
Brin, M.F.1
Lyons, K.E.2
Doucette, J.3
-
44
-
-
0030884685
-
Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor
-
Wissel J, Masuhr F, Schelosky L, et al. Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor. Mov Disord 1997;12:722-6.
-
(1997)
Mov Disord
, vol.12
, pp. 722-726
-
-
Wissel, J.1
Masuhr, F.2
Schelosky, L.3
-
45
-
-
0035909663
-
Tourette's syndrome
-
Jankovic J. Tourette's syndrome. N Engl J Med 2001;345:1184-92.
-
(2001)
N Engl J Med
, vol.345
, pp. 1184-1192
-
-
Jankovic, J.1
-
46
-
-
0033876785
-
Botulinum toxin in the treatment of tics
-
Kwak CH, Hanna PA, Jankovic J. Botulinum toxin in the treatment of tics. Arch Neurol 2000;57:1190-3.
-
(2000)
Arch Neurol
, vol.57
, pp. 1190-1193
-
-
Kwak, C.H.1
Hanna, P.A.2
Jankovic, J.3
-
47
-
-
0035852961
-
Botulinum toxin for simple motor tics: A randomized, double-blind, controlled clinical trial
-
Marras C, Andrews D, Sime EA, et al. Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology 2001;56:605-10.
-
(2001)
Neurology
, vol.56
, pp. 605-610
-
-
Marras, C.1
Andrews, D.2
Sime, E.A.3
-
48
-
-
17344389543
-
Recommendations for the use of botulinum toxin type A in the management of cerebral palsy
-
Graham HK, Aoki KR, Autti-Ramo I, et al. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture 2000;11:67-79.
-
(2000)
Gait Posture
, vol.11
, pp. 67-79
-
-
Graham, H.K.1
Aoki, K.R.2
Autti-Ramo, I.3
-
49
-
-
0033926243
-
Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: A randomized double blind placebo controlled trial
-
Bhakta BB, Cozens JA, Chamberlain A, et al. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomized double blind placebo controlled trial. J Neurol Neurosurg Psychiatry 2000;69:217-21.
-
(2000)
J Neurol Neurosurg Psychiatry
, vol.69
, pp. 217-221
-
-
Bhakta, B.B.1
Cozens, J.A.2
Chamberlain, A.3
-
50
-
-
18344414156
-
Management of upper limb dysfunction in children with cerebral palsy: A systematic review
-
Boyd RN, Morris ME, Graham HK. Management of upper limb dysfunction in children with cerebral palsy: a systematic review. Eur J Neurol 2001;8(suppl 5):150-66.
-
(2001)
Eur J Neurol
, vol.8
, Issue.5 SUPPL.
, pp. 150-166
-
-
Boyd, R.N.1
Morris, M.E.2
Graham, H.K.3
-
51
-
-
3042772864
-
The use af botulinum taxin in juvenile cerebral palsy
-
Brin MF, Hallett M, Jankavic J, eds. Philadelphia: Lippincott Williams & Wilkins
-
Delgado MR. The use af botulinum taxin in juvenile cerebral palsy. In: Brin MF, Hallett M, Jankavic J, eds. Scientific and therapeutic aspects of botulinum toxin. Philadelphia: Lippincott Williams & Wilkins, 2002:217-22.
-
(2002)
Scientific and Therapeutic Aspects of Botulinum Toxin
, pp. 217-222
-
-
Delgado, M.R.1
-
52
-
-
0036773435
-
Botulinum toxin treatment of spasticity in diplegic cerebral palsy: A randomized, double-blind, placebo-controlled, dose-ranging study
-
Boker R, Jasinski M, Maciag-Tymecka I, et al. Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging study. Dev Med Child Neurol 2002;44:666-75.
-
(2002)
Dev Med Child Neurol
, vol.44
, pp. 666-675
-
-
Boker, R.1
Jasinski, M.2
Maciag-Tymecka, I.3
-
53
-
-
0037043682
-
Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke
-
Brasheor A, Gordon MF, Elovic E, et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med 2002;347:395-400.
-
(2002)
N Engl J Med
, vol.347
, pp. 395-400
-
-
Brasheor, A.1
Gordon, M.F.2
Elovic, E.3
-
54
-
-
0344882590
-
Comparison of phenol block and botulinus toxin type A in the treatment of spastic foot after stroke: A randomized, double-blind trial
-
Kirazli Y, Yagiz On A, Kismali B, et al. Comparison of phenol block and botulinus toxin type A in the treatment of spastic foot after stroke: a randomized, double-blind trial. Am J Phys Med Rehabil 1998;77:510-15.
-
(1998)
Am J Phys Med Rehabil
, vol.77
, pp. 510-515
-
-
Kirazli, Y.1
Yagiz On, A.2
Kismali, B.3
-
55
-
-
0034067174
-
Botulinum toxin (Dysport ®) treatment of hip adductor in multiple sclerosis: A prospective, randomised, double blind, placebo controlled, dose ranging study
-
Hyman N, Barnes M, Bhakta B, et al. Botulinum toxin (Dysport ®) treatment of hip adductor in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study. J Neurol Neurosurg Psychiatry 2000;68:707-12.
-
(2000)
J Neurol Neurosurg Psychiatry
, vol.68
, pp. 707-712
-
-
Hyman, N.1
Barnes, M.2
Bhakta, B.3
-
56
-
-
0028962535
-
Botulinum toxin A for spasticity, muscle spasms, and rigidity
-
Grazko M, Polo KB, Jabbori B. Botulinum toxin A for spasticity, muscle spasms, and rigidity. Neurology 1995;45:712-17.
-
(1995)
Neurology
, vol.45
, pp. 712-717
-
-
Grazko, M.1
Polo, K.B.2
Jabbori, B.3
-
57
-
-
0027219703
-
Significant improvement of stiff-person syndrome after paraspinal injection of botulinum toxin A
-
Dovis D, Jabbari B. Significant improvement of stiff-person syndrome after paraspinal injection of botulinum toxin A. Mov Disord 1993;8:371-3.
-
(1993)
Mov Disord
, vol.8
, pp. 371-373
-
-
Dovis, D.1
Jabbari, B.2
-
58
-
-
9544250392
-
A randomised, double-blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients
-
Burbaud P, Wiart L, Dubos JL, et al. A randomised, double-blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. J Neurol Neurosurg Psychiatry 1996;61:265-9.
-
(1996)
J Neurol Neurosurg Psychiatry
, vol.61
, pp. 265-269
-
-
Burbaud, P.1
Wiart, L.2
Dubos, J.L.3
-
59
-
-
0035933051
-
Botulinum toxin A and chronic low back pain: A randomized, double-blind study
-
Foster L, Clapp L, Erickson M, et al. Botulinum toxin A and chronic low back pain: a randomized, double-blind study. Neurology 2001;56:1290-3.
-
(2001)
Neurology
, vol.56
, pp. 1290-1293
-
-
Foster, L.1
Clapp, L.2
Erickson, M.3
-
60
-
-
0036782213
-
Botulinum toxin therapy for myofascial pain disorders
-
Lang AM. Botulinum toxin therapy for myofascial pain disorders. Curr Pain Headache Rep 2002;6:355-60.
-
(2002)
Curr Pain Headache Rep
, vol.6
, pp. 355-360
-
-
Lang, A.M.1
-
61
-
-
0036884482
-
Botulinum toxin for the treatment of musculoskeletal pain and spasm
-
Sheeon G. Botulinum toxin for the treatment of musculoskeletal pain and spasm. Curr Pain Headache Rep 2002;6:460-9.
-
(2002)
Curr Pain Headache Rep
, vol.6
, pp. 460-469
-
-
Sheeon, G.1
-
62
-
-
1542329006
-
Botulinum toxin and other new approaches to migraine therapy
-
Ashkenazi A, Silberstein SD. Botulinum toxin and other new approaches to migraine therapy. Annu Rev Med 2004;55:505-18.
-
(2004)
Annu Rev Med
, vol.55
, pp. 505-518
-
-
Ashkenazi, A.1
Silberstein, S.D.2
-
63
-
-
0034883733
-
Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: A double-blind, placebo-controlled trial
-
Schmitt WJ, Slowey E, Fravi N, et al. Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache 2001;41:658-64.
-
(2001)
Headache
, vol.41
, pp. 658-664
-
-
Schmitt, W.J.1
Slowey, E.2
Fravi, N.3
-
64
-
-
0036834143
-
Treatment of headache with botulinum toxin A - A review according to evidence-based medicine criteria
-
Evens S, Rahmann A, Vollmer-Haase J, et al. Treatment of headache with botulinum toxin A - a review according to evidence-based medicine criteria. Cephalalgia 2002;22:699-710.
-
(2002)
Cephalalgia
, vol.22
, pp. 699-710
-
-
Evens, S.1
Rahmann, A.2
Vollmer-Haase, J.3
-
65
-
-
0037116179
-
Botulinum toxin A and the cutaneous nociception in humans: A prospective, double-blind, placebo-controlled, randomized study
-
Blersch W, Schulte-Mattler WJ, Przywara S, et al. Botulinum toxin A and the cutaneous nociception in humans: a prospective, double-blind, placebo-controlled, randomized study. J Neurol Sci 2002;205:59-63.
-
(2002)
J Neurol Sci
, vol.205
, pp. 59-63
-
-
Blersch, W.1
Schulte-Mattler, W.J.2
Przywara, S.3
-
66
-
-
0032839760
-
Botulinum toxin in the treatment of neurological disorders of the autonomic nervous system
-
Naumann M, Jost W, Toyka KV. Botulinum toxin in the treatment of neurological disorders of the autonomic nervous system. Arch Neurol 1999;56:914-16.
-
(1999)
Arch Neurol
, vol.56
, pp. 914-916
-
-
Naumann, M.1
Jost, W.2
Toyka, K.V.3
-
67
-
-
0035846569
-
Botulinum toxin type A in primary palmar hyperhidrosis. Randomized, single-blind, two-dase study
-
Saadia D, Voustianiouk A, Wang AK, et al. Botulinum toxin type A in primary palmar hyperhidrosis. Randomized, single-blind, two-dase study. Neurology 2001;57:2095-9.
-
(2001)
Neurology
, vol.57
, pp. 2095-2099
-
-
Saadia, D.1
Voustianiouk, A.2
Wang, A.K.3
-
68
-
-
0036885675
-
Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: A randomized controlled trial
-
Naumann MK, Lowe NJ. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial. Br J Dermatol 2002;147:1218-26.
-
(2002)
Br J Dermatol
, vol.147
, pp. 1218-1226
-
-
Naumann, M.K.1
Lowe, N.J.2
-
69
-
-
0035864927
-
Botulinum toxin A for axillary hyperhydrosis (excessive sweating)
-
Heckmann M, Ceballos-Baumann A, Plewig G, et al. Botulinum toxin A for axillary hyperhydrosis (excessive sweating). N Engl J Med 2001;344:488-93.
-
(2001)
N Engl J Med
, vol.344
, pp. 488-493
-
-
Heckmann, M.1
Ceballos-Baumann, A.2
Plewig, G.3
-
70
-
-
33845987422
-
Botulinum toxin, sweating, and body order
-
Heckmann M, Plewig G, Pause BM. Botulinum toxin, sweating, and body order. N Engl J Med 2002;347:620-1.
-
(2002)
N Engl J Med
, vol.347
, pp. 620-621
-
-
Heckmann, M.1
Plewig, G.2
Pause, B.M.3
-
71
-
-
0034126619
-
Injections of botulinum toxin A into the salivary glands improve sialorrhea in amyotrophic lateral sclerosis
-
Giess R, Naumann M, Werner E, et al. Injections of botulinum toxin A into the salivary glands improve sialorrhea in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2000;69:121-3.
-
(2000)
J Neurol Neurosurg Psychiatry
, vol.69
, pp. 121-123
-
-
Giess, R.1
Naumann, M.2
Werner, E.3
-
72
-
-
0035059822
-
Treatment of sialorrhea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders
-
Porta M, Gamba M, Bertacchi G, et al. Treatment of sialorrhea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders. J Neurol Neurosurg Psychiatry 2001;70:538-40.
-
(2001)
J Neurol Neurosurg Psychiatry
, vol.70
, pp. 538-540
-
-
Porta, M.1
Gamba, M.2
Bertacchi, G.3
-
73
-
-
0345830743
-
A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease
-
Ondo WG, Hunter C, Moore W. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease. Neurology 2004;62:37-40.
-
(2004)
Neurology
, vol.62
, pp. 37-40
-
-
Ondo, W.G.1
Hunter, C.2
Moore, W.3
-
74
-
-
0037061905
-
Botulinum toxin for cricopharyngeal dysfunction in Parkinson's disease
-
Restivo DA, Palmeri A, Marchese-Ragona R. Botulinum toxin for cricopharyngeal dysfunction in Parkinson's disease. N Engl J Med 2002;346:1174-5.
-
(2002)
N Engl J Med
, vol.346
, pp. 1174-1175
-
-
Restivo, D.A.1
Palmeri, A.2
Marchese-Ragona, R.3
-
75
-
-
0028922859
-
Intrasphincteric botulinum toxin for the treatment of achalasia
-
Pasricha PJ, Ravich WJ, Hendrix T, et al. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 1995;322:774-8.
-
(1995)
N Engl J Med
, vol.322
, pp. 774-778
-
-
Pasricha, P.J.1
Ravich, W.J.2
Hendrix, T.3
-
76
-
-
0031612067
-
Use of botulinum toxin in the treatment of achalasia
-
Schiano TD, Parkman HP, Miller LS, et al. Use of botulinum toxin in the treatment of achalasia. Dig Dis 1998;16:14-22.
-
(1998)
Dig Dis
, vol.16
, pp. 14-22
-
-
Schiano, T.D.1
Parkman, H.P.2
Miller, L.S.3
-
77
-
-
0030949772
-
Untoward effects of esophageal botulinum toxin injection in the treatment of achalasia
-
Eaker EY, Gordon JM, Vogel SB. Untoward effects of esophageal botulinum toxin injection in the treatment of achalasia. Dig Dis Sci 1997;42:724-7.
-
(1997)
Dig Dis Sci
, vol.42
, pp. 724-727
-
-
Eaker, E.Y.1
Gordon, J.M.2
Vogel, S.B.3
-
78
-
-
0028023716
-
Intrasphincteric injection of botulinum toxin for suspected sphincter of Oddi dysfunction
-
Pasricha PJ, Miskovsky EP, Kalloo AN. Intrasphincteric injection of botulinum toxin for suspected sphincter of Oddi dysfunction. Gut 1994;35:1319-21.
-
(1994)
Gut
, vol.35
, pp. 1319-1321
-
-
Pasricha, P.J.1
Miskovsky, E.P.2
Kalloo, A.N.3
-
79
-
-
10144219954
-
Initial North American experience with botulinum toxin a for treatment of anismus
-
Joo JS, Agachan F, Wollf B, et al. Initial North American experience with botulinum toxin a for treatment of anismus. Dis Colon Rectum 1996;39:1107-11.
-
(1996)
Dis Colon Rectum
, vol.39
, pp. 1107-1111
-
-
Joo, J.S.1
Agachan, F.2
Wollf, B.3
-
80
-
-
0030967764
-
Severe constipation in Parkinson's disease relieved by botulinum toxin
-
Albanese A, Maria G, Bentivoglio A, et al. Severe constipation in Parkinson's disease relieved by botulinum toxin. Mov Disord 1997;12:764-6.
-
(1997)
Mov Disord
, vol.12
, pp. 764-766
-
-
Albanese, A.1
Maria, G.2
Bentivoglio, A.3
-
81
-
-
0033536290
-
A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure
-
Brisinda G, Maria G, Bentivoglio AR, et al. A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N Engl J Med 1999;341:65-9.
-
(1999)
N Engl J Med
, vol.341
, pp. 65-69
-
-
Brisinda, G.1
Maria, G.2
Bentivoglio, A.R.3
-
82
-
-
0034594878
-
Treatment of neurogenic incontinence with botulinum toxin A
-
Schurch B, Schmid DM, Stohrer M. Treatment of neurogenic incontinence with botulinum toxin A. N Engl J Med 2000;342:665.
-
(2000)
N Engl J Med
, vol.342
, pp. 665
-
-
Schurch, B.1
Schmid, D.M.2
Stohrer, M.3
-
83
-
-
0032558305
-
Relief by botulinum toxin of voiding dysfunction due to prostatitis
-
Maria G, Destito A, Lacquanti S, et al. Relief by botulinum toxin of voiding dysfunction due to prostatitis. Lancet 1998;352:625.
-
(1998)
Lancet
, vol.352
, pp. 625
-
-
Maria, G.1
Destito, A.2
Lacquanti, S.3
-
84
-
-
0033755324
-
Perisphincteric injection of botulinum toxin type A. A treatment option for patients with chronic prostatic pain?
-
Zermann D, Ishigooka M, Schubert J, et al. Perisphincteric injection of botulinum toxin type A. A treatment option for patients with chronic prostatic pain? Eur Urol 2000;38:393-9.
-
(2000)
Eur Urol
, vol.38
, pp. 393-399
-
-
Zermann, D.1
Ishigooka, M.2
Schubert, J.3
-
85
-
-
0031015801
-
Treatment of vaginismus with botulinum toxin injections
-
Brin MF, Vapnek JM. Treatment of vaginismus with botulinum toxin injections. Lancet 1997;349:252-3.
-
(1997)
Lancet
, vol.349
, pp. 252-253
-
-
Brin, M.F.1
Vapnek, J.M.2
-
86
-
-
0028039081
-
Treatment of acquired nystagmus with botulinum neurotoxin A
-
Repka MX, Savino PJ, Reinecke RD. Treatment of acquired nystagmus with botulinum neurotoxin A. Arch Ophthalmol 1994;112:1320-4.
-
(1994)
Arch Ophthalmol
, vol.112
, pp. 1320-1324
-
-
Repka, M.X.1
Savino, P.J.2
Reinecke, R.D.3
-
87
-
-
0035412940
-
Case of essential palatal tremor: Atypical features and remarkable benefit from botulinum toxin injections
-
Cho JW, Chu K, Jeon BS. Case of essential palatal tremor: atypical features and remarkable benefit from botulinum toxin injections. Mov Disord 2001;16:779-82.
-
(2001)
Mov Disord
, vol.16
, pp. 779-782
-
-
Cho, J.W.1
Chu, K.2
Jeon, B.S.3
-
88
-
-
0037176811
-
Not paralysis, but dystonia causes stridor in multiple system atrophy
-
Merlo IM, Occhini A, Pacchetti C, et al. Not paralysis, but dystonia causes stridor in multiple system atrophy. Neurology 2002;58:649-52.
-
(2002)
Neurology
, vol.58
, pp. 649-652
-
-
Merlo, I.M.1
Occhini, A.2
Pacchetti, C.3
-
89
-
-
0034641273
-
Botulinum toxin treatment of cocontractions after birth-related brachial plexus lesions
-
Rollnik JD, Hierner R, Schubert M, et al. Botulinum toxin treatment of cocontractions after birth-related brachial plexus lesions. Neurology 2000;55:112-14.
-
(2000)
Neurology
, vol.55
, pp. 112-114
-
-
Rollnik, J.D.1
Hierner, R.2
Schubert, M.3
-
90
-
-
0031086708
-
Counterparalysis for treatment of paralytic scoliosis with botulinum toxin type A
-
Nuzzo RM, Walsh S, Boucherit T, et al. Counterparalysis for treatment of paralytic scoliosis with botulinum toxin type A. Am J Orthop 1997;3:201-5.
-
(1997)
Am J Orthop
, vol.3
, pp. 201-205
-
-
Nuzzo, R.M.1
Walsh, S.2
Boucherit, T.3
-
91
-
-
0034929154
-
The effect of botulinum toxin injections to the calf muscles on freezing of gait in parkinsonism: A pilot study
-
Giladi N, Gurevich T, Shabtai H, et al. The effect of botulinum toxin injections to the calf muscles on freezing of gait in parkinsonism: a pilot study. J Neurol 2001;248:572-6.
-
(2001)
J Neurol
, vol.248
, pp. 572-576
-
-
Giladi, N.1
Gurevich, T.2
Shabtai, H.3
-
92
-
-
0030066710
-
Perioperative use of botulinum toxin for movement disorders-induced cervical spine disease
-
Adler CH, Zimmerman RS Lyons MK, et al. Perioperative use of botulinum toxin for movement disorders-induced cervical spine disease. Mov Disord 1996;11:79-81.
-
(1996)
Mov Disord
, vol.11
, pp. 79-81
-
-
Adler, C.H.1
Zimmerman, R.S.2
Lyons, M.K.3
-
93
-
-
0037154137
-
Botulinum toxin-induced paralysis of frontotemporal muscles improves seizure focus localization
-
Eisenchenk S, Gilmore RL, Uthman B, et al. Botulinum toxin-induced paralysis of frontotemporal muscles improves seizure focus localization. Neurology 2002;58:246-9.
-
(2002)
Neurology
, vol.58
, pp. 246-249
-
-
Eisenchenk, S.1
Gilmore, R.L.2
Uthman, B.3
-
94
-
-
0242467375
-
Botulinum toxin a (Botox® Cosmetic). A review of its use in the treatment of glabellar frown lines
-
Frampton JE, Easthope SE. Botulinum toxin a (Botox® Cosmetic). A review of its use in the treatment of glabellar frown lines. Am J Clin Dermatol 2003;4:709-25.
-
(2003)
Am J Clin Dermatol
, vol.4
, pp. 709-725
-
-
Frampton, J.E.1
Easthope, S.E.2
-
97
-
-
0030066181
-
Treatment of facial synkinesis and facial asymmetry with botulinum toxin type A following facial nerve palsy
-
Armstrong MW, Mountain RE, Murray JA. Treatment of facial synkinesis and facial asymmetry with botulinum toxin type A following facial nerve palsy. Clin Otolaryngol 1996;21:15-20.
-
(1996)
Clin Otolaryngol
, vol.21
, pp. 15-20
-
-
Armstrong, M.W.1
Mountain, R.E.2
Murray, J.A.3
-
98
-
-
0031812134
-
Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy
-
Boroojerdi B, Ferbert A, Schwarz M, et al. Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy. J Neurol Neurosurg Psychiatry 1998;65:111-14.
-
(1998)
J Neurol Neurosurg Psychiatry
, vol.65
, pp. 111-114
-
-
Boroojerdi, B.1
Ferbert, A.2
Schwarz, M.3
-
99
-
-
0031448792
-
Cost-effectiveness of botulinum toxin type A injection in patients with spasticity following stroke: A German perspective
-
Wallesch C-W, Maes E, Lecomte P, et al. Cost-effectiveness of botulinum toxin type A injection in patients with spasticity following stroke: a German perspective. Eur J Neurol 1997;4(suppl 2):S53-7.
-
(1997)
Eur J Neurol
, vol.4
, Issue.2 SUPPL.
-
-
Wallesch, C.-W.1
Maes, E.2
Lecomte, P.3
-
100
-
-
0031795728
-
Effect of dystonia and botulinum toxin treatment on health-related quality of life
-
Gudex CM, Hawthorne MR, Butler AG, et al. Effect of dystonia and botulinum toxin treatment on health-related quality of life. Mov Disord 1998;13:941-6.
-
(1998)
Mov Disord
, vol.13
, pp. 941-946
-
-
Gudex, C.M.1
Hawthorne, M.R.2
Butler, A.G.3
|